Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanoma.
Mohr
Peter
P
Hauschild
Axel
A
Trefzer
Uwe
U
Weichenthal
Michael
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy* / Q000523:psychology* / Q000601:surgery; D011788:Quality of Life; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000523:psychology* / Q000601:surgery
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins